Suven Pharmaceuticals (BOM:543064) Other Operating Expense : ₹2,428 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals Other Operating Expense?

Suven Pharmaceuticals's Other Operating Expense for the three months ended in Mar. 2024 was ₹717 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹2,428 Mil.

Suven Pharmaceuticals's quarterly Other Operating Expense increased from Sep. 2023 (₹536 Mil) to Dec. 2023 (₹600 Mil) and increased from Dec. 2023 (₹600 Mil) to Mar. 2024 (₹717 Mil).

Suven Pharmaceuticals's annual Other Operating Expense increased from Mar. 2022 (₹1,449 Mil) to Mar. 2023 (₹1,828 Mil) and increased from Mar. 2023 (₹1,828 Mil) to Mar. 2024 (₹2,516 Mil).

Suven Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Suven Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals Other Operating Expense Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

855.14

1,107.32

1,449.15

1,828.38

2,516.26

Suven Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															451.80	574.91	536.29	600.03	716.59

Suven Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,428 Mil.

Suven Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals (BOM:543064) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » Other Operating Expense

Traded in Other Exchanges

SUVENPHAR:India

Address

3rd Floor, Road No. 5, Avenue 7, Banjara Hills, No. 8-2-334, SDE Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.

Suven Pharmaceuticals (BOM:543064) Headlines

No Headlines